COSMIC-021 Phase Ib study is evaluating Cabometyx® (cabozantinib) in combination with atezolizumab in advanced solid tumors, including non-small cell lung cancer New analyses from pivotal Phase III ...
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3 ASCO believes that cancer clinical trials are vital to inform medical decisions and ...
Seribantumab is a fully human IgG2 monoclonal antibody that binds to human epidermal growth factor receptor 3 (HER3). HER3 is traditionally activated through binding of its primary ligand, ...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that data for six approved medicines and pipeline candidates in more than 25 types ...
Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Dwight H. Owen, MD, MS; Navneet Singh, MD, DM; Nofisat Ismaila, MD, MSc; Elizabeth Blanchard, MD; Paul Celano, MD; Narjust Florez, MD; Dharamvir Jain, MD; Natasha B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results